Related Experiment Video

Updated: Jun 7, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases

Michelle L Varney1, Seema Singh, Aihua Li

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA.

Cancer Letters
|November 2, 2010
PubMed

Insights

Small molecule antagonists targeting CXCR1 and CXCR2 receptors inhibit colon cancer liver metastasis by reducing new blood vessel formation and increasing cancer cell death. These findings highlight a potential new therapeutic strategy for metastatic colon cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • CXCR1 and CXCR2 are G-protein coupled receptors implicated in tumor progression and metastasis.
  • These receptors represent promising targets for developing novel cancer therapeutics.

Purpose of the Study:

  • To investigate the efficacy of small molecule antagonists targeting CXCR1 and CXCR2 in inhibiting human colon cancer liver metastasis.
  • To elucidate the mechanisms underlying the anti-metastatic effects of CXCR1 and CXCR2 inhibition.

Main Methods:

  • Administration of orally active small molecule antagonists (SCH-527123, SCH-479833) targeting CXCR1 and CXCR2.
  • Evaluation of effects on primary tumor growth, liver metastasis, neovascularization, and malignant cell apoptosis in a human colon cancer model.

Main Results:

  • Targeting CXCR1 and CXCR2 significantly inhibited human colon cancer liver metastasis.
  • Inhibition was associated with decreased neovascularization and enhanced malignant cell apoptosis.
  • No significant differences were observed in primary tumor growth.

Conclusions:

  • CXCR1 and CXCR2 play a critical role in colon cancer liver metastasis.
  • Small molecule antagonists of CXCR1 and CXCR2 represent a promising therapeutic strategy for combating colon cancer metastasis.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...